Literature DB >> 22948774

Recurrent lymphoma in the thyroid gland detected by fluorine-18-fluorodeoxyglucose PET/CT.

Giorgio Treglia1, Annemilia Del Ciello, Davide Di Franco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22948774     DOI： 10.1007/s12020-012-9782-0

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  6 in total

1.  Massive thyroid involvement by marginal zone B cell NHL as demonstrated by 18F-FDG-PET/CT.

Authors:  Francesco Bertagna; Dragana Sobic-Saranovic; Vladimir Obradovic; Vera Artiko; Raffaele Giubbini; Abass Alavi
Journal:  Hell J Nucl Med       Date:  2009 Jan-Apr       Impact factor: 1.102

2.  Stage IE non-Hodgkin's thyroid lymphoma on (18)F-FDG-PET/CT.

Authors:  Amar Mehta; Ashok Muthukrishnan
Journal:  Hell J Nucl Med       Date:  2011 May-Aug       Impact factor: 1.102

3.  Fluorodeoxyglucose positron emission tomography in primary thyroid lymphoma with coexisting lymphocytic thyroiditis.

Authors:  Mohammad Arabi; Ryan Dvorak; Lauren B Smith; Lisa Kujawski; Milton D Gross
Journal:  Thyroid       Date:  2011-08-29       Impact factor: 6.568

4.  Prevalence and significance of thyroid uptake detected by ¹⁸F-FDG PET.

Authors:  Tsung-Ying Ho; Miaw-Jene Liou; Kun-Ju Lin; Tzu-Chen Yen
Journal:  Endocrine       Date:  2011-04-20       Impact factor: 3.633

Review 5.  Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas.

Authors:  Francesco Bertagna; Giorgio Treglia; Arnoldo Piccardo; Raffaele Giubbini
Journal:  J Clin Endocrinol Metab       Date:  2012-08-17       Impact factor: 5.958

6.  Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland.

Authors:  Dimitrios Karantanis; Trond V Bogsrud; Gregory A Wiseman; Brian P Mullan; Rathan M Subramaniam; Mark A Nathan; Patrick J Peller; Rebecca S Bahn; Val J Lowe
Journal:  J Nucl Med       Date:  2007-05-15       Impact factor: 10.057
  6 in total
  4 in total

Review 1.  Thyroid lymphoma: recent advances in diagnosis and optimal management strategies.

Authors:  Siun Walsh; Aoife J Lowery; Denis Evoy; Enda W McDermott; Ruth S Prichard
Journal:  Oncologist       Date:  2013-07-23

2.  Rituximab-including combined modality treatment for primary thyroid lymphoma: an effective regimen for elderly patients.

Authors:  Natsuko Watanabe; Hiroto Narimatsu; Jaeduk Yoshimura Noh; Yo Kunii; Koji Mukasa; Masako Matsumoto; Miho Suzuki; Kenichi Sekiya; Hidemi Ohye; Ai Yoshihara; Kenji Iwaku; Sakiko Kobayashi; Sachiko Kobayashi; Kaori Kameyama; Kazuhiko Kobayashi; Yoshitaka Nishikawa; Masahiro Kami; Kiminori Sugino; Koichi Ito
Journal:  Thyroid       Date:  2014-05-15       Impact factor: 6.568

3.  F18-FDG-PET/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value.

Authors:  Francesco Bertagna; Giorgio Treglia; Arnoldo Piccardo; Elisabetta Giovannini; Giovanni Bosio; Giorgio Biasiotto; El Khayat Bahij; Roberto Maroldi; Raffaele Giubbini
Journal:  Endocrine       Date:  2012-11-21       Impact factor: 3.633

4.  Tracheoesophageal fistula caused by chemotherapy in primary thyroid lymphoma: a case report.

Authors:  Chun Wang; Zhirong Li; Wuguo Tian
Journal:  Transl Cancer Res       Date:  2021-07       Impact factor: 1.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.